Neuraminidase enzymes are glycoside hydrolase enzymes that cleave (cut) the glycosidic linkages of neuraminic acids. The viral neuraminidases are frequently used as antigenic determinants found on the surface of the influenza virus.
This report contains market size and forecasts of Influenza NA Inhibitor in global, including the following market information:
Global Influenza NA Inhibitor Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Influenza NA Inhibitor Market Sales, 2017-2022, 2023-2028, (Kilotons)
Global top five Influenza NA Inhibitor companies in 2021 (%)
The global Influenza NA Inhibitor market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Zanamivir Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Influenza NA Inhibitor include Green Cross, Roche, GlaxoSmithKline, Henan DaKen Chemical, ATK Chemical, Chemwill Asia Co.,Ltd., Shionogi Co., NeoPharm and Moksha8 Pharma. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Influenza NA Inhibitor manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Influenza NA Inhibitor Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kilotons)
Global Influenza NA Inhibitor Market Segment Percentages, by Type, 2021 (%)
Zanamivir
Oseltamivir
Peramivir
Global Influenza NA Inhibitor Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kilotons)
Global Influenza NA Inhibitor Market Segment Percentages, by Application, 2021 (%)
Influenza A Treatment
Influenza B Treatment
Global Influenza NA Inhibitor Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kilotons)
Global Influenza NA Inhibitor Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Influenza NA Inhibitor revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Influenza NA Inhibitor revenues share in global market, 2021 (%)
Key companies Influenza NA Inhibitor sales in global market, 2017-2022 (Estimated), (Kilotons)
Key companies Influenza NA Inhibitor sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Green Cross
Roche
GlaxoSmithKline
Henan DaKen Chemical
ATK Chemical
Chemwill Asia Co.,Ltd.
Shionogi Co.
NeoPharm
Moksha8 Pharma